On September 1, 2022 Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, reported that Christopher Kirk, PhD, Co-founder, President and Chief Scientific Officer, will participate in three upcoming investor conferences in September (Press release, Kezar Life Sciences, SEP 1, 2022, View Source [SID1234618915]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Details:

Event: 2022 Wells Fargo Healthcare Conference
Location: Boston, MA
Date/Time: Thursday, September 8, 2022, at 1:20 PM ET
Format: Fireside Chat

Event: H.C. Wainwright 24th Annual Global Investment Conference
Location: New York, NY
Date/Time: Tuesday, September 13, 2022, at 11:30 AM ET
Format: Podium Presentation

Event: Morgan Stanley 20th Annual Global Healthcare Conference
Location: New York, NY
Date/Time: Wednesday, September 14, 2022, at 9:10 AM ET
Format: Fireside Chat

Webcasts from the presentations will be available on the "Events & Presentations" section of the Company’s website at www.kezarlifesciences.com. Following the events, archived webcasts will be available on the Kezar website for 90 days.